SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts📊Dashboards🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision
cell 682 words KG: disease
Contents

Pedunculopontine Nucleus Cholinergic Neurons in Lewy Body Disease

🧫 Cell Type Info
Cell Typedisease
Associated DiseasesALZHEIMER'S, ALZHEIMER'S DISEASE NEUROPATHOLOGY, ALZHEIMER'S
Related GenesACTB, AKT1, ATF6, ATG, ATG16L1, CASP3
Linked Hypotheses447 hypotheses

No AI portrait yet

Knowledge Graph

Related Hypotheses (199)

Circadian-Synchronized LRP1 Pathway Activation
Score: 0.71Purinergic Signaling Polarization Control
Score: 0.71Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.71HDAC3-Selective Inhibition for Clock Reset
Score: 0.71Metabolic Circuit Breaker via Lipid Droplet Modulation
Score: 0.71Autophagosome Maturation Checkpoint Control
Score: 0.71Matrix Stiffness Normalization via Targeted Lysyl Oxidase In
Score: 0.71Membrane Cholesterol Gradient Modulators
Score: 0.71Orexin-Microglia Modulation Therapy
Score: 0.71TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.71Lysosomal Enzyme Trafficking Correction
Score: 0.71Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat
Score: 0.71Microglial Efferocytosis Enhancement via GPR32 Superagonists
Score: 0.70Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.70Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration
Score: 0.70Microglial Purinergic Reprogramming
Score: 0.70Targeted Butyrate Supplementation for Microglial Phenotype M
Score: 0.70Mechanosensitive Ion Channel Reprogramming
Score: 0.70Lysosomal Calcium Channel Modulation Therapy
Score: 0.70Perforant Path Presynaptic Terminal Protection Strategy
Score: 0.70
← Prevpg 4/10Next →

Related Analyses (30)

Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completedSleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archivedRNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archivedSynaptic pruning by microglia in early AD
neurodegeneration · archivedTDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived

Related Experiments (30)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.45TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.45Microbiome-Gut-Brain Axis in Alzheimer's Disease — mechanism
clinical · proposed · Score: 0.40Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in
clinical · proposed · Score: 0.40

See Also (12)

ABCA7 (Redirect)
redirect · KG edge: activatesA2M Gene
gene · KG edge: implicated_inABCA1 - ATP-Binding Cassette Transporter A1
gene · KG edge: interacts_withABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member
gene · KG edge: associated_withABCD3 Gene
gene · KG edge: activates

Knowledge Graph (12 edges)

SLC16A2 implicated_in disease
SLC16A1 implicated_in disease
GSS implicated_in disease
CYP2E1 implicated_in disease
AKT1 activates disease
ATF6 activates disease
ATG16L1 activates disease
CGAS activates disease
CFTR activates disease
CASP3 activates disease

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

SciDEX — scidex.ai — Dashboard | Atlas